Chalasani N - Search Results

1

Incidence of Possible Drug-induced Liver Injury Due to Commonly Implicated Agents in the United States.

Lammert C, Teal E, Ghabril M, Chalasani N. Lammert C, et al. Among authors: chalasani n. Clin Gastroenterol Hepatol. 2024 Oct 22:S1542-3565(24)00950-9. doi: 10.1016/j.cgh.2024.09.012. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39447947 No abstract available.

2

Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes.

Chalasani N, Teal E, Hall SD. Chalasani N, et al. Am J Gastroenterol. 2005 Jun;100(6):1317-21. doi: 10.1111/j.1572-0241.2005.41690.x. Am J Gastroenterol. 2005. PMID: 15929763

3

Are there ethnicity-based differences in the evaluation of individuals with abnormal liver biochemistries?

Chalasani N, Saha C, Teal E. Chalasani N, et al. J Hepatol. 2007 Jul;47(1):123-7. doi: 10.1016/j.jhep.2007.01.037. Epub 2007 Mar 2. J Hepatol. 2007. PMID: 17399845 Free PMC article.

4

Deep vein thrombosis and pulmonary embolism in cirrhosis patients.

Gulley D, Teal E, Suvannasankha A, Chalasani N, Liangpunsakul S. Gulley D, et al. Among authors: chalasani n. Dig Dis Sci. 2008 Nov;53(11):3012-7. doi: 10.1007/s10620-008-0265-3. Epub 2008 Apr 29. Dig Dis Sci. 2008. PMID: 18443906

5

Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals.

Lammert C, Einarsson S, Saha C, Niklasson A, Bjornsson E, Chalasani N. Lammert C, et al. Among authors: chalasani n. Hepatology. 2008 Jun;47(6):2003-9. doi: 10.1002/hep.22272. Hepatology. 2008. PMID: 18454504

6

Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

Vuppalanchi R, Unalp A, Van Natta ML, Cummings OW, Sandrasegaran KE, Hameed T, Tonascia J, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. Clin Gastroenterol Hepatol. 2009 Apr;7(4):481-6. doi: 10.1016/j.cgh.2008.12.015. Epub 2008 Dec 25. Clin Gastroenterol Hepatol. 2009. PMID: 19162235 Free PMC article.

7

Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events.

Lammert C, Bjornsson E, Niklasson A, Chalasani N. Lammert C, et al. Among authors: chalasani n. Hepatology. 2010 Feb;51(2):615-20. doi: 10.1002/hep.23317. Hepatology. 2010. PMID: 19839004

8

Drug-induced liver injury: a clinical update.

Ghabril M, Chalasani N, Björnsson E. Ghabril M, et al. Among authors: chalasani n. Curr Opin Gastroenterol. 2010 May;26(3):222-6. doi: 10.1097/MOG.0b013e3283383c7c. Curr Opin Gastroenterol. 2010. PMID: 20186054 Free PMC article. Review.

9

Risk factors for idiosyncratic drug-induced liver injury.

Chalasani N, Björnsson E. Chalasani N, et al. Gastroenterology. 2010 Jun;138(7):2246-59. doi: 10.1053/j.gastro.2010.04.001. Epub 2010 Apr 12. Gastroenterology. 2010. PMID: 20394749 Free PMC article. Review.

10

Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt.

Vuppalanchi R, Juluri R, Ghabril M, Kim S, Thong N, Gorski JC, Chalasani N, Hall SD. Vuppalanchi R, et al. Among authors: chalasani n. J Clin Gastroenterol. 2011 Aug;45(7):638-42. doi: 10.1097/MCG.0b013e3181f8c522. J Clin Gastroenterol. 2011. PMID: 20962670

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

586 results

Search Page

Filters